(Q44351257)

English

High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study

scientific article published in February 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

author name string

Bengala C

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Danesi R

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Guarneri V

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Pazzagli I

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Donati S

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Favre C

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Fogli S

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Biadi O

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Innocenti F

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Del Tacca M

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mariani M

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Conte PF

12

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

275-280

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Evaluation of cardiac toxicity of idarubicin (4-demethoxydaunorubicin).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Penetration of idarubicin into malignant brain tumor tissue.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

21 January 2018

Comparative phase II study of idarubicin versus doxorubicin in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

7 January 2021

based on heuristic

inferred from DOI database lookup

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma pharmacokinetics of idarubicin and its 13-dihydro metabolite--a comparison of bolus versus 2 h infusion during a 3 day course.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

7 January 2021

based on heuristic

inferred from DOI database lookup

The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703827

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703827

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44351257&oldid=2206582955"